Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma.
about
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Phase Ib/II Study of the Safet ...... Advanced Soft Tissue Sarcoma.
@en
Phase Ib/II Study of the Safet ...... Advanced Soft Tissue Sarcoma.
@nl
type
label
Phase Ib/II Study of the Safet ...... Advanced Soft Tissue Sarcoma.
@en
Phase Ib/II Study of the Safet ...... Advanced Soft Tissue Sarcoma.
@nl
prefLabel
Phase Ib/II Study of the Safet ...... Advanced Soft Tissue Sarcoma.
@en
Phase Ib/II Study of the Safet ...... Advanced Soft Tissue Sarcoma.
@nl
P2093
P2860
P50
P1476
Phase Ib/II Study of the Safet ...... Advanced Soft Tissue Sarcoma.
@en
P2093
Ashley O'Connor
Christian Meyer
Joseph A Ludwig
Kenna Shaw
Marianna L Zahurak
Nilofer A Azad
Ralph Zinner
Vivek Subbiah
P2860
P304
P356
10.1158/1078-0432.CCR-17-0272
P407
P577
2017-04-04T00:00:00Z